Zaki Mohamed bought ADCT
February 13, 2026 · Form 4 insider transaction
Zaki Mohamed bought 285,200 shares of ADC Therapeutics SA at $3.99 per share, a transaction worth $1.14M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
285,200
Price
$3.99
Total value
$1.14M
InsiderZaki Mohamed
Role—
CompanyADC Therapeutics SA (ADCT)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2026
Filing dateFebruary 18, 2026
Shares owned after707,020
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2026, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event.